null

SMILES: CCOc1c(cc(Cl)c(C#N)c1C1CN(CC)C1)C(C)n1nc(C)c2c(N)ncnc12

InChI Key: InChIKey=LSKQFKWRGIDVRW-UHFFFAOYSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 261191   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta/delta isoform (Homo sapiens (Human))	BDBM261191 (US10092570, Example 214 | US10376513, Example 214 ...) Show SMILES CCOc1c(cc(Cl)c(C#N)c1C1CN(CC)C1)C(C)n1nc(C)c2c(N)ncnc12 Show InChI InChI=1S/C22H26ClN7O/c1-5-29-9-14(10-29)19-16(8-24)17(23)7-15(20(19)31-6-2)13(4)30-22-18(12(3)28-30)21(25)26-11-27-22/h7,11,13-14H,5-6,9-10H2,1-4H3,(H2,25,26,27)	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<10	n/a	n/a	n/a	n/a	6.7	25
Incyte Holdings Corporation; Incyte Corporation US Patent					Assay Description Lipid kinase substrate, phosphoinositol-4,5-bisphosphate (PIP2), are purchased from Echelon Biosciences (Salt Lake City, Utah). PI3K isoforms α,...				US Patent US9707233 (2017) BindingDB Entry DOI: 10.7270/Q2S46V0R
					More data for this Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (Homo sapiens (Human))	BDBM261191 (US10092570, Example 214 | US10376513, Example 214 ...) Show SMILES CCOc1c(cc(Cl)c(C#N)c1C1CN(CC)C1)C(C)n1nc(C)c2c(N)ncnc12 Show InChI InChI=1S/C22H26ClN7O/c1-5-29-9-14(10-29)19-16(8-24)17(23)7-15(20(19)31-6-2)13(4)30-22-18(12(3)28-30)21(25)26-11-27-22/h7,11,13-14H,5-6,9-10H2,1-4H3,(H2,25,26,27)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<10	n/a	n/a	n/a	n/a	6.7	25
Incyte Holdings Corporation; Incyte Corporation US Patent					Assay Description [γ-33P]ATP (10 mCi/mL) was purchased from Perkin-Elmer (Waltham, Mass.). Lipid kinase substrate, D-myo-Phosphatidylinositol 4,5-bisphosphate (Pt...				US Patent US10092570 (2018) BindingDB Entry DOI: 10.7270/Q2PZ5BW5
					More data for this Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (Homo sapiens (Human))	BDBM261191 (US10092570, Example 214 | US10376513, Example 214 ...) Show SMILES CCOc1c(cc(Cl)c(C#N)c1C1CN(CC)C1)C(C)n1nc(C)c2c(N)ncnc12 Show InChI InChI=1S/C22H26ClN7O/c1-5-29-9-14(10-29)19-16(8-24)17(23)7-15(20(19)31-6-2)13(4)30-22-18(12(3)28-30)21(25)26-11-27-22/h7,11,13-14H,5-6,9-10H2,1-4H3,(H2,25,26,27)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<10	n/a	n/a	n/a	n/a	n/a	n/a
Incyte Corporation; Incyte Holdings Corporation US Patent					Assay Description The kinase reaction was conducted in polystyrene 384-well matrix white plate from Thermo Fisher Scientific in a final volume of 25 uL. Inhibitors wer...				US Patent US10646492 (2020)
					More data for this Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (Homo sapiens (Human))	BDBM261191 (US10092570, Example 214 | US10376513, Example 214 ...) Show SMILES CCOc1c(cc(Cl)c(C#N)c1C1CN(CC)C1)C(C)n1nc(C)c2c(N)ncnc12 Show InChI InChI=1S/C22H26ClN7O/c1-5-29-9-14(10-29)19-16(8-24)17(23)7-15(20(19)31-6-2)13(4)30-22-18(12(3)28-30)21(25)26-11-27-22/h7,11,13-14H,5-6,9-10H2,1-4H3,(H2,25,26,27)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<10	n/a	n/a	n/a	n/a	n/a	n/a
Incyte Holdings Corporation US Patent					Assay Description [γ-33P]ATP (10 mCi/mL) was purchased from Perkin-Elmer (Waltham, Mass.). Lipid kinase substrate, D-myo-Phosphatidylinositol 4,5-bisphosphate (Pt...				US Patent US10376513 (2019) BindingDB Entry DOI: 10.7270/Q2GQ7142
					More data for this Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (Homo sapiens (Human))	BDBM261191 (US10092570, Example 214 | US10376513, Example 214 ...) Show SMILES CCOc1c(cc(Cl)c(C#N)c1C1CN(CC)C1)C(C)n1nc(C)c2c(N)ncnc12 Show InChI InChI=1S/C22H26ClN7O/c1-5-29-9-14(10-29)19-16(8-24)17(23)7-15(20(19)31-6-2)13(4)30-22-18(12(3)28-30)21(25)26-11-27-22/h7,11,13-14H,5-6,9-10H2,1-4H3,(H2,25,26,27)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<10	n/a	n/a	n/a	n/a	n/a	n/a
Incyte Holdings Corporation; Incyte Corporation US Patent					Assay Description [γ-33P]ATP (10 mCi/mL) was purchased from PerkinElmer (Waltham, Mass.). Lipid kinase substrate, D-myo-Phosphatidylinositol 4,5-bisphosphate (Ptd...				US Patent US9730939 (2017) BindingDB Entry DOI: 10.7270/Q2GB265W
					More data for this Ligand-Target Pair